查詢結果分析
相關文獻
- 纖維肌痛症
- 纖維肌痛症之介紹
- 惱人的慢性疼痛--纖維肌痛症候群
- 纖維肌痛症之診斷及致病機轉
- 惱人的慢性疼痛--談纖維肌痛症
- 認識神秘的纖維肌痛症
- 令病人、醫師困擾的纖維肌痛症候群
- Clinical Application of Pregabalin for the Treatments of Neuropathic Pain and Fibromyalgia: A Literature Review
- 漸被理解的纖維肌痛症
- Dose-Response of Pregabalin for Treatment of Chinese Patients with Fibromyalgia under New Diagnostic Criteria
頁籤選單縮合
題 名 | 纖維肌痛症之介紹=Introduction of Fibromyalgia |
---|---|
作 者 | 蔡敏鈴; 賴永融; 李建瑩; | 書刊名 | 藥學雜誌 |
卷 期 | 29:3=116 2013.09[民102.09] |
頁 次 | 頁87-91 |
分類號 | 415.9413 |
關鍵詞 | 纖維肌痛症; Fibromyalgia syndrome; FM; FMS; |
語 文 | 中文(Chinese) |
中文摘要 | 纖維肌痛症 (fibromyalgia syndrome,FM、FMS) 俗稱公主病,多發生於女性,且隨著年齡增加而發生率遞增。主要症狀為慢性疼痛、疲倦及失眠;病人會對壓力、溫度改變十分敏感,環境及情緒過度活動都可能引發症狀,真正發生原因不明,可能與神經傳導物質濃度上升有關。臨床常見的共病症,如憂鬱症、焦慮症、睡眠障礙、疲勞無力、頭痛等。 根據美國風濕病學會 (American College of Rheumatology, ACR) 2011年發表 FMS 診斷標準為:1.廣泛性疼痛指數 (wide spreadpain index,WPI),2.徵狀嚴重程度 (symptom severity scale, SS) ,若 WPI ≥ 7 & SS ≥ 5 或 WPI=3-6 & SS ≥ 9 ,3.症狀持續3個月及無法用其他疾病解釋,則診斷為纖維肌痛症。 美國食品暨藥物管理局目前核可於治療 FMS 之藥品有三種,分別為 pregabalin、duloxetine 及 minalcipran。在藥理上,前者屬於抗癲癇藥,後兩者屬於抗憂鬱劑,台灣衛生署目前僅核准 pregabalin 使用於 FMS。而歐洲抗風濕病協會 (European League Against Rheumatism, EULAR) 提出之 FMS 治療指引則包括止痛劑 (tramadol)、抗憂鬱劑 (amitriptyline、fluoxetine、duloxetine、milnacipran、moclobemide 及 pirlindole) 及中樞神經系統藥品 (tropisetron、pramipexole 及 pregabalin) 等。 除了藥物的治療之外,病人還需接受復健治療、心理治療等等,規律的生活及運動也有助於症狀的緩解。FMS 預後常不理想多只能部分症狀緩解,因此,更需要家人及醫療團隊在疾病過程中予以支持及強化病人的治療動機、自信及參與度。如此,才是治療成功之道。 |
英文摘要 | Fibromyalgia (FM or FMS) is a medical disorder characterized by chronic widespread pain and allodynia, a heightened and painful response to pressure. It is estimated to affect about 2% of the whole world population, with a female to male incidence ratio of approximately 9:1. FMS has been fraught with ambiguity in diagnosis, uncertainty in understanding of its pathophysiology, and difficulties for physicians in managing it competently. In 2010, the American College of Rheumatology (ACR) diagnostic criteria for FMS included widespread pain index (WPI) and symptom severity (SS) scale. The SS scale and the WPI were then combined to form a new case definition of FMS: WPI of 7 or higher and SS of 5 or higher or WPI of 3 to 6 and SS of 9 or higher. There are 3 FDA-approved medications for the treatment of fibromyalgia. Two of them, duloxetine and milnacipran, are considered SNRI agents, and the other one, pregabalin, is considered anticonvulsant agent. Furthermore, other medications can help reduce the pain of fibromyalgia and improve sleep including nonsteroidal anti-inflammatory drugs (NSAIDs), narcotic analgesics, antidepressants and anti-seizure drugs. As with many other medically unexplained syndromes, there is no universally accepted treatment or cure for fibromyalgia. Indeed, integrated treatment plans that incorporate medication, patient education, aerobic exercise and cognitive-behavioral therapy have been shown to be effective in alleviating pain and other fibromyalgia-related symptoms. |
本系統中英文摘要資訊取自各篇刊載內容。